Cassava Sciences Inc vs Veritone Inc — how do they compare? Cassava Sciences Inc trades at $0.97 (market cap $47.75M), while Veritone Inc trades at $1.5 (market cap $138.04M). The key difference: Veritone Inc is far larger — about 2.9× Cassava Sciences Inc's market cap. Which is the better fit depends on your goals.
| FLNA | VERI | |
|---|---|---|
Market Cap | $47.75M | $138.04M |
Sector | Health | Technology |
52-Week High | $4.64 | $8.39 |
52-Week Low | $0.87 | $1.00 |
Enterprise Value | -$34.93M | $170.07M |
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $0.9973, up 0.23% with a bearish technical signal despite recent earnings beats. The company shows negative profitability with ROE at -55.79% and ROA at -35.34%, though cash burn improved from -$33M to -$30M projected for 2026. Analyst consensus is strongly bullish with 8 buy ratings versus 4 hold ratings.
The outlook remains challenging due to persistent losses and negative cash flow, but analyst optimism and continued progress in TSC-related epilepsy therapies provide potential catalysts. Key risks include execution challenges in clinical development and the company's ability to secure additional funding.
No Aura AI signal available yet.
Trailing returns across standard periods
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →Veritone is a leading provider of enterprise AI software and solutions, centered on its proprietary AI operating system, aiWARE™. The platform orchestrates a vast ecosystem of machine learning models to transform unstructured data—such as audio, video, and text—into actionable intelligence. Serving the media, entertainment, and public sectors, Veritone is a critical infrastructure partner for organizations looking to monetize data archives and operationalize AI at scale.
Read more on VERI →